Showing results (811-820 of 826) with videos related to
Sort By:
Pageof 83
Journal of Medicinal Chemistry|December 21, 2019
Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational AnalysisMathieu Rappas, Ammar A E Ali, Kirstie A Bennett, et al.Journal of Genomics|March 2, 2019
SELfies and CELLfies: Whole Genome Sequencing and Annotation of Five Antibiotic Resistant Bacteria Isolated from the Surfaces of Smartphones, An Inquiry Based Laboratory Exercise in a Genomics Undergraduate Course at the Rochester Institute of TechnologyAnutthaman Parthasarathy, Narayan H Wong, Amanda N Weiss, et al.Toxicology and Applied Pharmacology|May 19, 2026
Combined acylated catalpol diglycoside and Lactobacillus therapy restores the miR-146a-TRAF6-SIRT1/AMPK signaling axis in experimental colitisAhmed M El-Baz, Reham M Gouda, Hany Baraka, et al.Genome Medicine|April 8, 2009
Race and ancestry in biomedical research: exploring the challengesTimothy Caulfield, Stephanie M Fullerton, Sarah E Ali-Khan, et al.Public Health Action|September 25, 2015
Open access for operational research publications from low- and middle-income countries: who pays?R Zachariah, A M V Kumar, A J Reid, et al.Biorxiv : the Preprint Server for Biology|June 19, 2024
An epigenetically distinct HSC subset supports thymic reconstitutionHarold K Elias, Sneha Mitra, Marina B da Silva, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonistsR M Keenan, W H Miller, M A Lago, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis modelR M Keenan, M A Lago, W H Miller, et al.Frontiers in Oncology|December 2, 2022
Ultrastructural analysis of zinc oxide nanospheres enhances anti-tumor efficacy against HepatomaAmr Hassan, Fawziah A Al-Salmi, Tamer M M Abuamara, et al.European Review for Medical and Pharmacological Sciences|September 26, 2023
Effect of dapagliflozin against NAFLD and dyslipidemia in type 2 diabetic albino rats: possible underlying mechanismsW M Said Ahmed, A Soliman, A E Ahmed Amer, et al.Pageof 83